Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $27.7900 (-0.71%) ($27.6100 - $28.3000) on Tue. Jul. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.7% (three month average) | RSI | 75 | Latest Price | $27.7900(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.4% a day on average for past five trading days. | Weekly Trend | HALO advances 7.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(49%) IWM(47%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.35% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-14%) TLT(-2%) IYT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.35% (StdDev 2.7%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $27.7(0.32%) | 10 Day Moving Average | $26.57(4.59%) | 20 Day Moving Average | $25.19(10.32%) | To recent high | -2.5% | To recent low | 66.7% | Market Cap | $3.798b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |